- Type
-
Identity
- Human Adult Cancer-HuCAT
- Human Adult Normal-HuFPT
- Human Benign Lesions-HuDAT
- Monkey (Cynomolgus) (Normal)- CyFPT
- Monkey (Rhesus) (Normal)-RsFPT
- Mouse (Normal)-MoFPT
- Paired Cancer And Normal-NCT
- Rat (Normal)-RaFPT
- Human-Pulmonary mesothelioma
- Human-Glioblastoma Multiforme (GBM)
- Human-Multiple Sclerosis
- Human-Brain Tissue
- Human-Chronic pancreatitis
- Human-Children
- Human-Chronic Active Hepatitis (CAH)
- Human-Lung Inflammation
- Human-Uterine Adenomyosis
- Human-Endometriosis
- Human-Pediatric Sarcomas
-
Organ
- Liver
- Esophagus
- Ovary
- Stomach
- Lung
- Colon
- Rectum
- Kidney
- Breast
- Endometrium
- Uterus
- Bladder
- Pancreas
- Skin
- Penis
- Testis
- Soft_Tissue
- Bone/Cartilage
- Oral/Cavity
- Bone/Marrow
- Heart
- Spleen
- Head/Neck
- Vulva
- Melanoma
- Appendix
- Intestine
- Adrenal Gland
- Thymus
- Fallopian tube
- Mouse
- Fetus
- Rat
- Monkey (Rhesus) (Normal)-RsFPT
- Monkey (Cynomolgus) (Normal)-CyFPT
- Dog
- Multiple organ
- Gall bladder and bile duct
- Esophagogastric junction
-
Types/Disease
- Lymphoma
- Melanoma
- Embryonic tumors
- Metastasis
- Parasite
- Mesothelioma
- Pulmonary squamous cell carcinoma
- Pulmonary adenocarcinoma
- Small cell lung cancer
- Thymomas
- Tumors of the heart
- Esophageal carcinoma
- Gastric cardia cancer
- Gastric carcinoma
- Carcinama of the small intestine
- Carcinama of the colon
- Carcinama of the rectum
- Tumors of the appendix
- Liver cancer
- Gallbladder cancer
- Pancreatic cancer
- Renal cell carcinoma
- Adrenal tumors
- Bladder cancer
- Breast carcinoma
- Ovary Carcinoma
- Fallopian tube cancer
- cervical carcinoma
- Endometrial carcinoma
- Vulvar tumor
- Penile carcinoma
- Prostate cancer
- Testis tumor
- Head and neck tumors
- Nasopharyngeal carcinoma
- Thyroid carcinoma
- Skin cancer
- Naevus
- Malignant melanoma
- Bone marrow tumor
- Spleen tumors
- Malignant lymphoma
- Neural tumor
- Brain tumor
- Endocrine tumor
- Leiomyosarcoma
- Liposarcoma
- Fibrosarcoma
- Chondrosarcoma
- Rhabdomyosarcoma
- Osteosarcoma
- Desmoplastic small round cell tumor
- Cynomolgus monkey
- Rhesus monkey
- Embryonic tumors
- FDA999( 32 types of normal human organs)
- Adenocarcinoma
- Non-Small cell lung cancer
- Renal chromophobe cell carcinoma
- Cores
- Cases
-
Cores:4CASES:4Core Diameter(mm):2Thickness(µm):5Row number:1Column number:4Tissue Array Type:FFPESpecies:Human
Add To
CollectDescription: PD-L1 tested non-small cell lung cancer tissue array, which is suitable for tumor immunotherapy, including pathology grade, TNM, clinical stage and PD-L1(Sp263) information, 4 cases/4 core, replacing LC04
Details: PD-L1 tested non-small cell lung carcinoma tissue microarray, which is suitable for tumor immunotherapy, containing 3 cases PD-L1(Sp263) is positive and 1 is negative (with 1 adenocarcinoma and 2 squamous cell carcinoma are positive and 1 squamous cell carcinoma is negative), single core per case
Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page
1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning. 2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."
-
Specification sheet
-
Overlapping case
-
Download specifications
-
Malignant(IB)
-
Malignant(IIA)
-
Malignant(IIIA)
RLN04a
|
1
|
2
|
3
|
4
|
|
|
A
|
{"id":122659,"pid":1593,"update_time":"2025-01-17 16:06:04","create_time":"2025-01-17 16:06:04","pos":"A1","cs_0":"1","cs_1":"57","cs_2":"M","cs_3":"Lung","cs_4":"Adenocarcinoma","cs_5":"1","cs_6":"T2N1M0","cs_7":"IIA","cs_8":"Rln050203","cs_9":"Malignant","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"","cs_21":"","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"TC\u226525%","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null}
Lun
|
{"id":122660,"pid":1593,"update_time":"2025-01-17 16:06:04","create_time":"2025-01-17 16:06:04","pos":"A2","cs_0":"2","cs_1":"63","cs_2":"M","cs_3":"Lung","cs_4":"Squamous cell carcinoma","cs_5":"2","cs_6":"T3N1M0","cs_7":"IIIA","cs_8":"Rln110009","cs_9":"Malignant","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"","cs_21":"","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"TC\u226585%","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null}
Lun
|
{"id":122661,"pid":1593,"update_time":"2025-01-17 16:06:04","create_time":"2025-01-17 16:06:04","pos":"A3","cs_0":"3","cs_1":"62","cs_2":"M","cs_3":"Lung","cs_4":"Squamous cell carcinoma","cs_5":"3","cs_6":"T2N0M0","cs_7":"IB","cs_8":"Rln060121","cs_9":"Malignant","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"","cs_21":"","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"TC\u226525%","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null}
Lun
|
{"id":122662,"pid":1593,"update_time":"2025-01-17 16:06:04","create_time":"2025-01-17 16:06:04","pos":"A4","cs_0":"4","cs_1":"50","cs_2":"F","cs_3":"Lung","cs_4":"Squamous cell carcinoma","cs_5":"3","cs_6":"T2N0M0","cs_7":"IB","cs_8":"Rln100114","cs_9":"Malignant","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"","cs_21":"","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"-","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null}
Lun
|
-
Age:
-
Sex:
-
Organ/Anatomic Site:
-
Pathology diagnosis:
-
Grade:
-
TNM:
-
Stage:
-
Tissue ID.:
-
Type:
| Pos | No. | Age | Sex | Organ/Anatomic Site | Pathology diagnosis | Grade | TNM | Stage | Type | PD-L1(Sp263) |
|---|---|---|---|---|---|---|---|---|---|---|
|
A1
|
1 | 57 | M | Lung | Adenocarcinoma | 1 | T2N1M0 | IIA | Malignant | TC≥25% |
|
A2
|
2 | 63 | M | Lung | Squamous cell carcinoma | 2 | T3N1M0 | IIIA | Malignant | TC≥85% |
|
A3
|
3 | 62 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant | TC≥25% |
|
A4
|
4 | 50 | F | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant | - |
Download
